[HTML][HTML] Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance

Y Wang, Y Chen, J Zhang, Y Yang, JS Fleishman… - Drug Resistance …, 2024 - Elsevier
Cuproptosis is a newly identified form of cell death driven by copper. Recently, the role of
copper and copper triggered cell death in the pathogenesis of cancers have attracted …

Selective targeting of cancer cells by copper ionophores: an overview

V Oliveri - Frontiers in molecular biosciences, 2022 - frontiersin.org
Conventional cancer therapies suffer from severe off-target effects because most of them
target critical facets of cells that are generally shared by all rapidly proliferating cells. The …

Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis

D Ramchandani, M Berisa, DA Tavarez, Z Li… - Nature …, 2021 - nature.com
Copper serves as a co-factor for a host of metalloenzymes that contribute to malignant
progression. The orally bioavailable copper chelating agent tetrathiomolybdate (TM) has …

Copper in tumors and the use of copper-based compounds in cancer treatment

DA da Silva, A De Luca, R Squitti, M Rongioletti… - Journal of inorganic …, 2022 - Elsevier
Copper homeostasis is strictly regulated by protein transporters and chaperones, to allow its
correct distribution and avoid uncontrolled redox reactions. Several studies address copper …

The multifaceted roles of copper in cancer: A trace metal element with dysregulated metabolism, but also a target or a bullet for therapy

P Lelièvre, L Sancey, JL Coll, A Deniaud, B Busser - Cancers, 2020 - mdpi.com
Simple Summary Copper is an essential element for human life. However, its redox activity
can be detrimental for the cell that developed highly coordinated pathways to chelate and …

Identification of copper metabolism-related subtypes and establishment of the prognostic model in ovarian cancer

S Zhao, X Zhang, F Gao, H Chi, J Zhang… - Frontiers in …, 2023 - frontiersin.org
Background Ovarian cancer (OC) is one of the most common and most malignant
gynecological malignancies in gynecology. On the other hand, dysregulation of copper …

Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4

Z Skrott, M Mistrik, KK Andersen, S Friis, D Majera… - Nature, 2017 - nature.com
Cancer incidence is rising and this global challenge is further exacerbated by tumour
resistance to available medicines. A promising approach to meet the need for improved …

Modulation of intracellular copper levels as the mechanism of action of anticancer copper complexes: Clinical relevance

MV Babak, D Ahn - Biomedicines, 2021 - mdpi.com
Copper (Cu) is a vital element required for cellular growth and development; however, even
slight changes in its homeostasis might lead to severe toxicity and deleterious medical …

Enhanced Tumor-Specific Disulfiram Chemotherapy by In Situ Cu2+ Chelation-Initiated Nontoxicity-to-Toxicity Transition

W Wu, L Yu, Q Jiang, M Huo, H Lin… - Journal of the …, 2019 - ACS Publications
The antitumor activity of disulfiram (DSF), a traditional US Food and Drug Administration-
approved drug for the treatment of “alcohol-dependence”, is Cu2+-dependent, but the …

Cellular plasticity and the neuroendocrine phenotype in prostate cancer

AH Davies, H Beltran, A Zoubeidi - Nature Reviews Urology, 2018 - nature.com
The success of next-generation androgen receptor (AR) pathway inhibitors, such as
abiraterone acetate and enzalutamide, in treating prostate cancer has been hampered by …